FVY-29193-56463
3 vaccinations
2 coded responses
33 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 917 / CA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-13
-
2021-01-22
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-26
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Fatigue or tirednessFree text: Mild DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-02-07
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-04-25
-
2021-07-23
Survey response — 6 months, dose 2MedDRA: Dizziness, Headache — Feeling: FairFree text: Headache and dizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Headache, Muscle or body achesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-24
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2022-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Mild Dizzy
Release 9 — 6 months, dose 2
Symptoms: Headache and dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release